K. Funaoka , M. Arisue , I. Kobayashi , T. Iizuka , T. Kohgo , A. Amemiya , Y. Totsuka
{"title":"23例成釉细胞瘤增殖细胞核抗原(PCNA)的免疫组化检测","authors":"K. Funaoka , M. Arisue , I. Kobayashi , T. Iizuka , T. Kohgo , A. Amemiya , Y. Totsuka","doi":"10.1016/0964-1955(96)00007-3","DOIUrl":null,"url":null,"abstract":"<div><p>Ameloblastoma is the most frequent odontogenic tumour. It occurs mainly in the mandible and grows expansively. The treatment of ameloblastoma, which influences the prognosis, is decided in consideration of many factors, especially the age and size of the tumour. Conservative treatment sometimes leads to the recurrence of tumours and poor prognosis, but the relationships between the prognosis and the cytological features of tumour cells are still unclear. In the present study, we examined the immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma and evaluated the correlation between the positive index of PCNA and the clinical and histological character. Our results revealed the higher the age of the patient the greater was the incidence of a positive index of PCNA. It was also shown that the mean positive PCNA index in the follicular type (34.56 ± 14.00 S.D.) was higher than that of the plexiform type (24.436 ± 15.74 S.D., <em>P</em> < 0.10). The cystic type showed a low positive PCNA index (14.75 ± 8.41 S.D.). In the follicular type, the localisation of PCNA-positive cells was different according to the histological patterns of tumours. Additionally, the positive indices of the same patient differed at different periods of treatment.</p></div>","PeriodicalId":77118,"journal":{"name":"European journal of cancer. Part B, Oral oncology","volume":"32 5","pages":"Pages 328-332"},"PeriodicalIF":0.0000,"publicationDate":"1996-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0964-1955(96)00007-3","citationCount":"39","resultStr":"{\"title\":\"Immunohistochemical detection of Proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma\",\"authors\":\"K. Funaoka , M. Arisue , I. Kobayashi , T. Iizuka , T. Kohgo , A. Amemiya , Y. Totsuka\",\"doi\":\"10.1016/0964-1955(96)00007-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Ameloblastoma is the most frequent odontogenic tumour. It occurs mainly in the mandible and grows expansively. The treatment of ameloblastoma, which influences the prognosis, is decided in consideration of many factors, especially the age and size of the tumour. Conservative treatment sometimes leads to the recurrence of tumours and poor prognosis, but the relationships between the prognosis and the cytological features of tumour cells are still unclear. In the present study, we examined the immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma and evaluated the correlation between the positive index of PCNA and the clinical and histological character. Our results revealed the higher the age of the patient the greater was the incidence of a positive index of PCNA. It was also shown that the mean positive PCNA index in the follicular type (34.56 ± 14.00 S.D.) was higher than that of the plexiform type (24.436 ± 15.74 S.D., <em>P</em> < 0.10). The cystic type showed a low positive PCNA index (14.75 ± 8.41 S.D.). In the follicular type, the localisation of PCNA-positive cells was different according to the histological patterns of tumours. Additionally, the positive indices of the same patient differed at different periods of treatment.</p></div>\",\"PeriodicalId\":77118,\"journal\":{\"name\":\"European journal of cancer. Part B, Oral oncology\",\"volume\":\"32 5\",\"pages\":\"Pages 328-332\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/0964-1955(96)00007-3\",\"citationCount\":\"39\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of cancer. Part B, Oral oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/0964195596000073\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of cancer. Part B, Oral oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0964195596000073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 39
摘要
成釉细胞瘤是最常见的牙源性肿瘤。它主要发生在下颌骨,生长迅速。成釉细胞瘤的治疗是由许多因素决定的,尤其是肿瘤的年龄和大小。保守治疗有时会导致肿瘤复发,预后差,但预后与肿瘤细胞的细胞学特征之间的关系尚不清楚。本研究对23例成釉细胞瘤的增殖细胞核抗原(PCNA)进行了免疫组化检测,并评价了PCNA阳性指标与临床和组织学特征的相关性。我们的结果显示,患者年龄越高,PCNA阳性指数的发生率越大。滤泡型的平均阳性PCNA指数(34.56±14.00 S.D)高于丛状型(24.436±15.74 S.D), P <0.10)。囊型低阳性PCNA指数(14.75±8.41 S.D.)。在滤泡型中,根据肿瘤的组织学模式,pcna阳性细胞的定位是不同的。此外,同一患者在不同治疗时期的阳性指标也存在差异。
Immunohistochemical detection of Proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma
Ameloblastoma is the most frequent odontogenic tumour. It occurs mainly in the mandible and grows expansively. The treatment of ameloblastoma, which influences the prognosis, is decided in consideration of many factors, especially the age and size of the tumour. Conservative treatment sometimes leads to the recurrence of tumours and poor prognosis, but the relationships between the prognosis and the cytological features of tumour cells are still unclear. In the present study, we examined the immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma and evaluated the correlation between the positive index of PCNA and the clinical and histological character. Our results revealed the higher the age of the patient the greater was the incidence of a positive index of PCNA. It was also shown that the mean positive PCNA index in the follicular type (34.56 ± 14.00 S.D.) was higher than that of the plexiform type (24.436 ± 15.74 S.D., P < 0.10). The cystic type showed a low positive PCNA index (14.75 ± 8.41 S.D.). In the follicular type, the localisation of PCNA-positive cells was different according to the histological patterns of tumours. Additionally, the positive indices of the same patient differed at different periods of treatment.